Literature DB >> 3510922

Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.

R R Henry, T A Wiest-Kent, L Scheaffer, O G Kolterman, J M Olefsky.   

Abstract

To determine the effects of very-low-calorie diets on the metabolic abnormalities of diabetes and obesity, we have studied 10 obese, non-insulin-dependent diabetic (NIDDM) and 5 obese, nondiabetic subjects for 36 days on a metabolic ward during consumption of a liquid diet of 300 kcal/day with 30 g of protein. Rapid improvement occurred in the glycemic indices of the diabetic subjects, with mean (+/- SEM) fasting plasma glucose falling from 291 +/- 21 to 95 +/- 6 mg/dl (P less than 0.001) and total glycosylated hemoglobin from 13.1 +/- 0.7% to 8.8 +/- 0.3% (P less than 0.001) (normal reference range 5.5-8.5%). Lipid elevations were normalized with plasma triglycerides reduced to less than 100 mg/dl and total plasma cholesterol to less than 150 mg/dl in both groups. Hormonal and substrate responses were also comparable between groups with reductions in insulin and triiodothyronine and moderate elevations in blood and urinary ketoacid levels without a corresponding rise in free fatty acids. Electrolyte balance for sodium, potassium, calcium, and phosphorus was initially negative but approached equilibrium by completion of the study. Magnesium, in contrast, remained in positive balance in both groups throughout. Total nitrogen loss varied widely among all subjects, ranging from 70 to 367 g, and showed a strong positive correlation with initial lean body mass (N = 0.83, P less than 0.001) and total weight loss (N = 0.87, P less than 0.001). The nondiabetic group, which had a significantly greater initial body weight and lean body mass than the diabetic group, also had a significantly greater weight loss of 450 +/- 31 g/day compared with 308 +/- 19 g/day (P less than 0.01) in the diabetic subjects. The composition of the weight lost at completion was similar in both groups and ranged from 21.6% to 31.3% water, 3.9% to 7.8% protein, and 60.9% to 74.5% fat. The contribution of both water and protein progressively decreased and fat increased, resulting in unchanged caloric requirements during the diet. This study demonstrates that short-term treatment with a very-low-calorie diet in both obese diabetic and nondiabetic subjects results in: safe and effective weight loss associated with the normalization of elevated glucose and lipid levels, a large individual variability in total nitrogen loss determined principally by the initial lean body mass, and progressive increments in the contribution of fat to weight loss with stable caloric requirements and no evidence of a hypometabolic response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510922     DOI: 10.2337/diab.35.2.155

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  Studies in insulin resistance following very low calorie diet and/or gastric bypass surgery.

Authors:  Jonathan Foo; Jeremy Krebs; Mark Thomas Hayes; Damon Bell; Donia Macartney-Coxson; Tony Croft; Richard Strawson Stubbs
Journal:  Obes Surg       Date:  2011-12       Impact factor: 4.129

Review 2.  Obesity. Part I--Pathogenesis.

Authors:  G A Bray; D S Gray
Journal:  West J Med       Date:  1988-10

3.  RARgamma and TRbeta expressions are decreased in PBMC and SWAT of obese subjects in weight gain.

Authors:  C Bairras; A Redonnet; H Dabadie; H Gin; C Atgie; V Pallet; P Higueret; C Noël-Suberville
Journal:  J Physiol Biochem       Date:  2010-04-13       Impact factor: 4.158

4.  Successful weight loss and maintenance in everyday clinical practice with an individually tailored change of eating habits on the basis of food energy density.

Authors:  Volker Schusdziarra; Margit Hausmann; Corina Wiedemann; Julie Hess; Cornelia Barth; Stefan Wagenpfeil; Johannes Erdmann
Journal:  Eur J Nutr       Date:  2010-12-01       Impact factor: 5.614

Review 5.  Who should undergo a very low energy diet?

Authors:  M J Müller; R Grossklaus
Journal:  Clin Investig       Date:  1993-12

6.  Change in predicted 10-year cardiovascular risk following Roux-en-Y gastric bypass surgery: who benefits?

Authors:  Simara P Donadelli; Wilson Salgado; Julio S Marchini; Andre Schmidt; Cristiana A F Amato; Reginaldo Ceneviva; Jose Ernesto Dos Santos; Carla Barbosa Nonino
Journal:  Obes Surg       Date:  2011-05       Impact factor: 4.129

Review 7.  Aggressive diets and lipid responses.

Authors:  Claudia Panzer; Caroline M Apovian
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

8.  Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.

Authors:  J B Schmidt; S D Pedersen; N T Gregersen; L Vestergaard; M S Nielsen; C Ritz; S Madsbad; D Worm; D L Hansen; T R Clausen; J F Rehfeld; A Astrup; J J Holst; A Sjödin
Journal:  Int J Obes (Lond)       Date:  2013-08-25       Impact factor: 5.095

9.  Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes.

Authors:  Blandine Laferrère; Julio Teixeira; James McGinty; Hao Tran; Joseph R Egger; Antonia Colarusso; Betty Kovack; Baani Bawa; Ninan Koshy; Hongchan Lee; Kimberly Yapp; Blanca Olivan
Journal:  J Clin Endocrinol Metab       Date:  2008-04-22       Impact factor: 5.958

10.  Challenges to Healthy Eating Practices: A Qualitative Study of Non-Hispanic Black Men Living With Diabetes.

Authors:  Loretta T Lee; Amanda L Willig; April A Agne; Julie L Locher; Andrea L Cherrington
Journal:  Diabetes Educ       Date:  2016-04-01       Impact factor: 2.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.